Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

NCT06992583 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Lung Cancer

Interventions

BIOLOGICAL: Targeted CEA CAR-T
BIOLOGICAL: Targeted CEA CAR-T

Sponsor

Chongqing Precision Biotech Co., Ltd